In such cases, JAK2 V617F could have been a mutation of clonal hematopoiesis of indeterminate potential (CHIP) whose VAF was below the detection limit of conventional sequencing or NGS assays for many years prior to diagnosis of an MPN. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.